CCL22 and Alzheimer disease: Thymus and activation-regulated chemokine (TARC or CCL17) as well as macrophage-derived chemokine (MDC or CCL22), which are Th2 chemokines, mediate the migration of lymphocytes to inflammatory sites and aggravate AD [15].